Submission Timeline
Submissions open: Wednesday, November 11, 2026
Submission deadline: January 9, 2027
Submitters will be notified of their status the week of January 25, 2027.
Abstract Guidelines
- Abstracts may be a maximum of 250 words. The title, author names, affiliations, tables, and figures are not included in the word count.
- Up to two tables or figures may be included per abstract.
- Submissions are welcome from industry, academic, and clinical authors, including fellows. Case reports are accepted.
- Encore presentations are accepted, including encores of previously published work. Please list the original meeting or publication, date, and location in the Comments field of the application.
- Abstracts must be submitted through the application.
Poster Guidelines
- A PDF of the poster must be uploaded together with the abstract through the application.
- Posters should be submitted as a single-page PDF.
- There is no limit to the number of authors on an abstract or poster.
- Authors do not need to be present at the meeting for their abstract and poster to be accepted.
RWCS does not offer oral presentations.
Display and Selection
- All accepted abstracts and posters will be available to attendees on the conference digital platform.
- A faculty panel will select several posters for physical display on poster boards in the exhibit area.
- Submitters whose posters are selected will be notified the week of January 25, 2027, and are responsible for printing their poster and bringing it to the meeting. Poster boards are 4 ft tall x 8 ft wide (48" x 96"), so please size your printed poster to fit.
Avoidance of Commercialism
Any poster of which the cost is underwritten to any extent by a pharmaceutical company or other commercial enterprise must avoid commercialism. Trade names must not be used for drugs, devices, and/or instrumentation, including lasers. In addition, such a poster should include a clear but inconspicuous acknowledgment stating that a portion of its cost was underwritten and identifying the commercial company involved. No advertising material of any kind may be distributed, nor will any material be displayed which, in any way, directly promotes the commercial interest of any particular company, enterprise, or the exhibitor. Any medications or other substances, devices, or equipment referred to in poster materials must be identified by their scientific names.
Note: Sponsorship or funding by a commercial enterprise must be noted in the lower right-hand corner of the poster. Failure to do so will result in the poster being removed.
AI Use Disclosure
Authors may use generative AI tools (for example, for writing assistance, data visualization, or editing) in preparing abstracts and posters. If AI was used in any part of the submission, please include a brief disclosure describing the tool(s) used and how they were used. Authors remain responsible for the accuracy, originality, and integrity of the content.
Questions
Please contact Jackie Kuniyoshi at jkuniyoshi@mjhevents.com.
